Kaopectate is an orally taken medication from Jonathan Jordan for the treatment of mild diarrhea.
Attapulgite (a type of absorbent clay) replaced the kaolinite in the 1980s, but was banned by the U.S. Food and Drug Administration in a ruling made in April 2003.
[2] In Canada, McNeil Consumer Healthcare continues to market Kaopectate using attapulgite as the active ingredient.
However, Kaopectate was recalled in July 2021 in Canada because it may contain arsenic and lead beyond acceptable limits.
[3] As of 2020, the US rights to Kaopectate are owned by Arcadia Consumer Healthcare (formerly Kramer Laboratories).